缺血性卒中后的易栓症检测:为何、何时与查什么
本文综述缺血性卒中患者易栓症检测的现有证据,指出遗传性易栓症与缺血性卒中的关联不确定,而抗磷脂综合征似乎是动脉血栓栓塞事件(包括缺血性卒中)的强危险因素,尤其在年轻患者中。文章提出年轻卒中、隐源性卒中及高雌激素状态等情形可考虑针对性检测,并呼吁未来开展前瞻性研究评估检测效用与成本效益。
要点
- 遗传性易栓症与缺血性卒中的关联不确定,不应常规检测。
- 抗磷脂综合征是动脉血栓栓塞事件的强危险因素,尤其在年轻患者中。
- 年轻卒中、隐源性卒中及高雌激素状态可考虑针对性易栓症检测。
核心结论
- 遗传性易栓症与缺血性卒中的关系不确定,而抗磷脂综合征似乎是动脉血栓栓塞事件(包括缺血性卒中)的强危险因素,尤其在年轻患者中。
研究设计与样本
- 本文为 topical review,复习并情境化现有关于缺血性卒中患者易栓症风险、预测因素和结局的数据。
主要发现
- 遗传性易栓症与缺血性卒中的关系不确定。
- 抗磷脂综合征似乎是动脉血栓栓塞事件(包括缺血性卒中)的强危险因素,尤其在年轻患者中。
临床怎么用
- 某些情形可考虑针对性易栓症检测,如年轻卒中、隐源性卒中及高雌激素状态。
- 未来需前瞻性研究评估不同卒中背景下易栓症检测的效用与成本效益,包括卵圆孔未闭患者。
- 未来需研究确诊易栓症患者的最佳二级卒中预防方案,尤其当未发现其他潜在卒中机制时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombophilia testing is frequently performed after an ischemic stroke, particularly when cryptogenic. However, there is minimal evidence supporting a significant association between most conditions assessed through thrombophilia testing and ischemic stroke, and the rationale for thrombophilia testing in many clinical situations remains uncertain. In this topical review, we review and contextualize the existing data on the risks, predictors, and outcomes of thrombophilic conditions in patients with ischemic stroke. We report that inherited thrombophilias have an uncertain relationship with ischemic stroke. Conversely, antiphospholipid syndrome, an acquired immune-mediated thrombophilia, seems to be a strong risk factor for arterial thromboembolic events, including ischemic stroke, and especially among young patients. Our findings suggest that certain circumstances may warrant targeted thrombophilia testing, such as stroke in the young, cryptogenic stroke, and high estrogen states. Future prospective studies should investigate the utility and cost effectiveness of thrombophilia testing in various stroke settings, including among patients with patent foramen ovale; as well as the optimal secondary stroke prevention regimen in patients with confirmed thrombophilia, particularly if no other potential stroke mechanism is identified.
引用
- Salehi Omran S, Hartman A, Zakai NA, et al. Thrombophilia Testing After Ischemic Stroke: Why, When, and What? Stroke. 2021. PMID: 33874743. doi:10.1161/STROKEAHA.120.032360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。